Inventor
TANI KOUSUKE
JP33 patents
⚠️ This page may combine multiple inventors who share the name “TANI KOUSUKE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ONO PHARMACEUTICAL CO
30 patentsUS6110969AAug 29, 2000
Cycloalkyl-prostaglandin E2 derivatives
ONO PHARMACEUTICAL CO57 citations96
US10201520B2Feb 12, 2019
Bicyclic compound and use thereof for medical purposes
ONO PHARMACEUTICAL CO10 citations92
US9889114B2Feb 13, 2018
Bicyclic compound and use thereof for medical purposes
ONO PHARMACEUTICAL CO9 citations92
US8962868B2Feb 24, 2015
Bicyclic compound and use thereof for medical purposes
ONO PHARMACEUTICAL CO14 citations92
US7786161B2Aug 31, 2010
Carboxylic acid derivatives and pharmaceutical agent comprising the same as active ingredient
ONO PHARMACEUTICAL CO21 citations92
US7491748B2Feb 17, 2009
Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient
ONO PHARMACEUTICAL CO46 citations92
US7402605B2Jul 22, 2008
8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
ONO PHARMACEUTICAL CO38 citations92
US6710205B2Mar 23, 2004
Benzoic acid derivatives, processes for producing the same and drugs containing the same as the active ingredient
ONO PHARMACEUTICAL CO22 citations92
US6262293B1Jul 17, 2001
ω-Cycloalkly-prostaglandin e2 derivatives
ONO PHARMACEUTICAL CO48 citations92
US6235780B1May 22, 2001
ω-cycloalkyl-prostaglandin E1 derivatives
ONO PHARMACEUTICAL CO44 citations92
US9388157B2Jul 12, 2016
Bicyclic compound and use thereof for medical purposes
ONO PHARMACEUTICAL CO9 citations84
US7196198B2Mar 27, 2007
Benzoic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient
ONO PHARMACEUTICAL CO14 citations84
US6835752B2Dec 28, 2004
Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient
ONO PHARMACEUTICAL CO19 citations83
US7858650B2Dec 28, 2010
Medicinal composition for inhalation
ONO PHARMACEUTICAL CO18 citations81
US7256211B1Aug 14, 2007
8-azaprostaglandin derivatives and medical use thereof
ONO PHARMACEUTICAL CO12 citations81
US10077247B2Sep 18, 2018
Tricyclic spiro compound
ONO PHARMACEUTICAL CO4 citations80
US11617733B2Apr 4, 2023
Bicyclic compound and use thereof for medical purposes
ONO PHARMACEUTICAL CO1 citations73
US10940134B2Mar 9, 2021
Bicyclic compound and use thereof for medical purposes
ONO PHARMACEUTICAL CO2 citations73
US7683094B2Mar 23, 2010
8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
ONO PHARMACEUTICAL CO6 citations73
US11192876B2Dec 7, 2021
Tricyclic spiro compound
ONO PHARMACEUTICAL CO2 citations69
US10538502B2Jan 21, 2020
Tricyclic spiro compound
ONO PHARMACEUTICAL CO2 citations69
US6576785B1Jun 10, 2003
ω-cycloalkyl-prostaglandin E2 derivatives
ONO PHARMACEUTICAL CO3 citations63
US12201603B2Jan 21, 2025
Bicyclic compound and use thereof for medical purposes
ONO PHARMACEUTICAL CO0 citations62
US11479550B2Oct 25, 2022
EP4 antagonist
ONO PHARMACEUTICAL CO1 citations61
US12497377B2Dec 16, 2025
Tricyclic spiro compound
ONO PHARMACEUTICAL CO0 citations59
US8026273B2Sep 27, 2011
8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
ONO PHARMACEUTICAL CO0 citations51
US9643940B2May 9, 2017
Amine salt and crystals thereof
ONO PHARMACEUTICAL CO0 citations42
US9771357B2Sep 26, 2017
ALXR agonist compound
ONO PHARMACEUTICAL CO0 citations39
US10385045B2Aug 20, 2019
Compound having EP2 agonist activity
ONO PHARMACEUTICAL CO0 citations37
US9890146B2Feb 13, 2018
Compound having selective EP2 agonist activity
ONO PHARMACEUTICAL CO0 citations37